Content about Business Relation

ABBOTT PARK, Ill. Drug makers Abbott and Reata Pharmaceuticals have signed an agreement concerning a drug for chronic kidney disease.

The two companies said Thursday that they would develop and commercialize bardoxolone methyl, currently in mid-stage clinical trials.

NEW YORK The federal government got a kick in the face Thursday as an appeals court ruled in favor of patent litigation settlements between branded and generic drug companies.

RALEIGH, N.C. Salix Pharmaceuticals announced its agreement with Novel Labs to settle its patent litigation over Novel’s proposed generic version of MoviPrep.

SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday.

The FDA approved generic enoxaparin sodium, a version of Sanofi’s Lovenox, developed under a collaboration between Momenta Pharmaceuticals and Sandoz, the generics division of Swiss drug maker Novartis.

WHAT IT MEANS AND WHY IT'S IMPORTANT Duane Reade’s sale to Walgreens means a lot of things, but one thing that won’t happen is that it will lose the unique identity that the chain has carved out in its hometown of New York, which allowed it to set itself apart from other retail pharmacies in the area. And in the process, Duane Reade is helping to redefine what a retail pharmacy can do and be.

(THE NEWS: Duane Reade teams up with JagTag. For the full story, click here)